Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial

T. Powles*, S.S. Sridhar, Y. Loriot, J. Bellmunt, X.J. Mu, K.A. Ching, J. Pu, C.N. Sternberg, D.P. Petrylak, R. Tambaro, L.M. Dourthe, C. Alvarez-Fernandez, M. Aarts, A. di Pietro, P. Grivas, C.B. Davis*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology